Literature DB >> 33330776

Sustaining containment of COVID-19: global sharing for pandemic response.

Hiroaki Mitsuya1, Norihiro Kokudo1.   

Abstract

The coronavirus disease 2019 (COVID-19) outbreak, caused by SARS-CoV-2, has rapidly escalated into a global pandemic. One of our significant concerns is that we have no data as to whether people, who acquired immunity against this deadly virus and recovered from COVID-19, are protected from further infections with the same virus. Moreover, we have no data as to whether this pandemic will persist in our societies and continue vexing us for long periods of time. Implementing science-based response strategy is essential to sustain containment of COVID-19 globally. Rapidly sharing scientific information means providing real-time research data and relevant findings. As an international academic journal, Global Health & Medicine publishes this special issue entitled "GHM Special Topic: COVID-19". It includes a range of articles describing COVID-19 based on frontline data from Japan, China, the United States, Italy, the United Kingdom, and other countries and areas worldwide. Our hope is that the rapid publication and sharing of information contribute, in whichever possible way, to this global fight against COVID-19. 2020, National Center for Global Health and Medicine.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; global health

Year:  2020        PMID: 33330776      PMCID: PMC7731181          DOI: 10.35772/ghm.2020.01040

Source DB:  PubMed          Journal:  Glob Health Med        ISSN: 2434-9186


  11 in total

Review 1.  Effects of COVID-19 vaccination on FDG-PET/CT imaging: A literature review.

Authors:  Ryogo Minamimoto; Tomomichi Kiyomatsu
Journal:  Glob Health Med       Date:  2021-06-30

2.  COVID-19 in Japan: An update on national policy, research, clinical practice, and vaccination campaign.

Authors:  Peipei Song; Hiroaki Mitsuya; Norihiro Kokudo
Journal:  Glob Health Med       Date:  2022-04-30

Review 3.  The SARS-CoV-2 main protease (Mpro): Structure, function, and emerging therapies for COVID-19.

Authors:  Qing Hu; Yuan Xiong; Guang-Hao Zhu; Ya-Ni Zhang; Yi-Wen Zhang; Ping Huang; Guang-Bo Ge
Journal:  MedComm (2020)       Date:  2022-07-14

4.  Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure-Activity Relationships, Antiviral Activity, and X-ray Structure Determination.

Authors:  Thanigaimalai Pillaiyar; Philipp Flury; Nadine Krüger; Haixia Su; Laura Schäkel; Elany Barbosa Da Silva; Olga Eppler; Thales Kronenberger; Tianqing Nie; Stephanie Luedtke; Cheila Rocha; Katharina Sylvester; Marvin R I Petry; James H McKerrow; Antti Poso; Stefan Pöhlmann; Michael Gütschow; Anthony J O'Donoghue; Yechun Xu; Christa E Müller; Stefan A Laufer
Journal:  J Med Chem       Date:  2022-06-16       Impact factor: 8.039

5.  Design of Novel Enantiopure Dispirooxindolopyrrolidine-Piperidones as Promising Candidates toward COVID-19: Asymmetric Synthesis, Crystal Structure and In Silico Studies.

Authors:  Amani Toumi; Sarra Boudriga; Yasmine M Mandour; Ahmed A Mekki; Michael Knorr; Carsten Strohmann; Jan-Lukas Kirchhoff; Mansour Sobeh
Journal:  Molecules       Date:  2022-06-20       Impact factor: 4.927

6.  A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication.

Authors:  Shin-Ichiro Hattori; Nobuyo Higashi-Kuwata; Hironori Hayashi; Srinivasa Rao Allu; Jakka Raghavaiah; Haydar Bulut; Debananda Das; Brandon J Anson; Emma K Lendy; Yuki Takamatsu; Nobutoki Takamune; Naoki Kishimoto; Kazutaka Murayama; Kazuya Hasegawa; Mi Li; David A Davis; Eiichi N Kodama; Robert Yarchoan; Alexander Wlodawer; Shogo Misumi; Andrew D Mesecar; Arun K Ghosh; Hiroaki Mitsuya
Journal:  Nat Commun       Date:  2021-01-28       Impact factor: 14.919

7.  Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals.

Authors:  Kenji Maeda; Masayuki Amano; Yukari Uemura; Kiyoto Tsuchiya; Tomoko Matsushima; Kenta Noda; Yosuke Shimizu; Asuka Fujiwara; Yuki Takamatsu; Yasuko Ichikawa; Hidehiro Nishimura; Mari Kinoshita; Shota Matsumoto; Hiroyuki Gatanaga; Kazuhisa Yoshimura; Shin-Ichi Oka; Ayako Mikami; Wataru Sugiura; Toshiyuki Sato; Tomokazu Yoshida; Shinya Shimada; Hiroaki Mitsuya
Journal:  Sci Rep       Date:  2021-11-24       Impact factor: 4.379

8.  Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.

Authors:  Yuki Takamatsu; Masaki Imai; Kenji Maeda; Noriko Nakajima; Nobuyo Higashi-Kuwata; Kiyoko Iwatsuki-Horimoto; Mutsumi Ito; Maki Kiso; Tadashi Maemura; Yuichiro Takeda; Kazumi Omata; Tadaki Suzuki; Yoshihiro Kawaoka; Hiroaki Mitsuya
Journal:  J Virol       Date:  2021-11-24       Impact factor: 5.103

9.  Building back better from COVID-19: Knowledge, emergence and social contracts.

Authors:  Mark Pelling; Helen Adams; George Adamson; Alejandro Barcena; Sophie Blackburn; Maud Borie; Amy Donovan; Anshu Ogra; Faith Taylor; Lu Yi
Journal:  Prog Hum Geogr       Date:  2022-02

10.  Correlates of Neutralizing/SARS-CoV-2-S1-binding Antibody Response with Adverse Effects and Immune Kinetics in BNT162b2-Vaccinated Individuals.

Authors:  Kenji Maeda; Masayuki Amano; Yukari Uemura; Kiyoto Tsuchiya; Tomoko Matsushima; Kenta Noda; Yosuke Shimizu; Asuka Fujiwara; Yuki Takamatsu; Yasuko Ichikawa; Hidehiro Nishimura; Mari Kinoshita; Shota Matsumoto; Hiroyuki Gatanaga; Kazuhisa Yoshimura; Shin-Ichi Oka; Ayako Mikami; Wataru Sugiura; Toshiyuki Sato; Tomokazu Yoshida; Shinya Shimada; Hiroaki Mitsuya
Journal:  medRxiv       Date:  2021-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.